
Opinion|Videos|August 1, 2024
Future Possibilities in IPF Treatment
Author(s)Steven D. Nathan, MD
Dr Nathan discusses the trajectory of IPF management.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do you envision these investigational agents potentially being implemented into future treatment paradigms for idiopathic pulmonary fibrosis (IPF)?
- Cell-based therapies represent another modality being explored for IPF. What is the potential impact of this type of treatment?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers
2
FDA Approves Gene Therapy Onasemnogene Abeparvovec for Broader SMA Population
3
FDA Approves Durvalumab With FLOT Chemotherapy for Resectable Gastric and Gastroesophageal Junction Cancer
4
Patients Face New Care Complexities as DTC Options Expand
5
















































